<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>This is something our workgroup in New England would like to focus on this year. I have not had our intern pull literature on this, yet, but wasn’t there a study done in Las Vegas on quantifying sources?<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Stevan Gressitt [mailto:gressitt@gmail.com] <br><b>Sent:</b> Thursday, January 05, 2012 7:41 PM<br><b>To:</b> Lucy, Burke<br><b>Cc:</b> pharmwaste@lists.dep.state.fl.us<br><b>Subject:</b> Re: [Pharmwaste] Re: Cytotoxic Chemotherapy drugs/groundwater connection<o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><div><p class=MsoNormal>Maybe it is time to offer a reward for someone who CAN quantify that difference...<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><p class=MsoNormal><o:p> </o:p></p><div><p class=MsoNormal>On Thu, Jan 5, 2012 at 1:57 PM, Lucy, Burke <<a href="mailto:Burke.Lucy@calrecycle.ca.gov">Burke.Lucy@calrecycle.ca.gov</a>> wrote:<o:p></o:p></p><div><div><p>Sorry I’m no help with the cytotoxic chemotheraphy drug contamination issue but in slide #10 in the presentation to Senator Whitehouse sent in the previous e-mail and copied below, I’m curious where exactly the text quantifying drug disposal destinations comes from that references Dr. Daughton’s <a href="http://www.google.com/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CCcQFjAA&url=http%3A%2F%2Fwww.epa.gov%2Fnerlesd1%2Fbios%2Fdaughton%2FAPM200-2010.pdf&ei=vOUFT9umM9TYiQL63a2ADA&usg=AFQjCNFTZeyhoeFcsW0n1nKOu1v_szj1nw&sig2=KwP3kkclw66rGI8tyzN9-w" target="_blank">Drugs and the Environment: Stewardship & Sustainability</a> report. I was only able to find this on pages 17-18: "The question as to what fraction of collective or individual API residues in the aquatic environment emanates from direct disposal versus excretion and bathing is currently not answerable."<o:p></o:p></p><p> <o:p></o:p></p><p><img border=0 width=632 height=421 id="_x0000_i1025" src="cid:image001.jpg@01CCCC4D.E65D15F0"><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'> <o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'> <o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'> <o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'> <o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'> <o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'>Burke Lucy<o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'>Integrated Waste Management Specialist<o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'>Department of Resources Recycling and Recovery (CalRecycle)<o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'>1001 I Street, PO Box 4025<o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'>Sacramento, CA 95812<o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><a href="mailto:Burke.Lucy@CalRecycle.ca.gov" target="_blank">Burke.Lucy@CalRecycle.ca.gov</a><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><a href="tel:916.341.6592" target="_blank">916.341.6592</a><o:p></o:p></p><p> <o:p></o:p></p><p>-----Original Message-----<br>From: <a href="mailto:pharmwaste-bounces@lists.dep.state.fl.us" target="_blank">pharmwaste-bounces@lists.dep.state.fl.us</a> [mailto:<a href="mailto:pharmwaste-bounces@lists.dep.state.fl.us" target="_blank">pharmwaste-bounces@lists.dep.state.fl.us</a>] On Behalf Of Tenace, Laurie<br>Sent: Thursday, January 05, 2012 7:22 AM<br>To: <a href="mailto:pharmwaste@lists.dep.state.fl.us" target="_blank">pharmwaste@lists.dep.state.fl.us</a><br>Subject: [Pharmwaste] FW: Cytotoxic Chemotherapy drugs/groundwater connection<o:p></o:p></p><p> <o:p></o:p></p><p>Forward for Marjorie Copeland at EPA<o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p>Please take a few minutes to share your comments on the service you received from the department by clicking on this link Copy the url below to a web browser to complete the DEP survey: <a href="http://survey.dep.state.fl.us/?refemail=Laurie.Tenace@dep.state.fl.us" target="_blank">http://survey.dep.state.fl.us/?refemail=Laurie.Tenace@dep.state.fl.us</a><o:p></o:p></p><p> <o:p></o:p></p><p>From: Marjorie Copeland <a href="mailto:[mailto:Copeland.Marjorie@epamail.epa.gov]" target="_blank"><span style='color:windowtext;text-decoration:none'>[mailto:Copeland.Marjorie@epamail.epa.gov]</span></a><o:p></o:p></p><p>Sent: Thursday, January 05, 2012 9:50 AM<o:p></o:p></p><p>To: <a href="mailto:pharmwaste@lists.dep.state.fl.us" target="_blank"><span style='color:windowtext;text-decoration:none'>pharmwaste@lists.dep.state.fl.us</span></a><o:p></o:p></p><p>Subject: Fw: Cytotoxic Chemotherapy drugs/groundwater connection<o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p>Hi, Everyone<o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p>Marjorie W. Copeland<o:p></o:p></p><p>Environmental Protection Agency, Mail Code 4606M Office of Ground Water and Drinking Water<o:p></o:p></p><p>1200 Pennsylvania Ave. NW<o:p></o:p></p><p>Washington, DC 20460-0001<o:p></o:p></p><p><a href="tel:%28202%29%20564-3876" target="_blank">(202) 564-3876</a><o:p></o:p></p><p>FAX <a href="tel:%28202%29%20564-3754" target="_blank">(202) 564-3754</a><o:p></o:p></p><p> <o:p></o:p></p><p>Is anyone familiar with the emerging issue of cytotoxic chemotheraphy drugs contamination, if any other states besides Rhode Island and Massachusetts are focusing on related policy, or the broadness of the issue which appears to be a specific PPCP concern? I'm also interested in finding information regarding ground water contamination from cytotoxic chemotherapy drugs.<o:p></o:p></p><p> <o:p></o:p></p><p>See email below on topic from a colleague who works for EPA Region 1 on source water protection.<o:p></o:p></p><p> <o:p></o:p></p><p>Thanks,<o:p></o:p></p><p>Marjorie<o:p></o:p></p><p> <o:p></o:p></p><p>----- Forwarded by Marjorie Copeland/DC/USEPA/US on 01/05/2012 09:19 AM<o:p></o:p></p><p>-----<o:p></o:p></p><p> <o:p></o:p></p><p>From: Kira Jacobs/R1/USEPA/US<o:p></o:p></p><p>To: Roy Simon/DC/USEPA/US@EPA, <a href="mailto:Copeland.Marjorie@epa.gov" target="_blank"><span style='color:windowtext;text-decoration:none'>Copeland.Marjorie@epa.gov</span></a><o:p></o:p></p><p>Date: 01/04/2012 06:11 PM<o:p></o:p></p><p>Subject: Cytotoxic Chemotherapy drugs/groundwater connection<o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p>Roy and Marjorie,<o:p></o:p></p><p> <o:p></o:p></p><p>I am working with my colleague Ernie Panciera at Rhode Island DEM on this emerging issue (see memo below on interpretation of Rhode Island groundwater regs). Have you heard any discussion about this issue? It seems more specific than the broader PPCP issue.<o:p></o:p></p><p> <o:p></o:p></p><p>RIDEM asked me to check with GWPC to get the national perspective. I spoke to Mike Paque yesterday and he's going to talk to Ben G. about it when he gets back in the office.<o:p></o:p></p><p> <o:p></o:p></p><p>For now, the focus on policy seems limited to Rhode Island and Massachusetts. See bill proposed in the MA legislature this session and PowerPoint presentation given to Sen. Whitehouse (Rhode Island).<o:p></o:p></p><p> <o:p></o:p></p><p>(See attached file: MA 2011 Bill S01089 (1).pdf)(See attached file:<o:p></o:p></p><p>Pharma-Cycle_Senator.ppt)<o:p></o:p></p><p> <o:p></o:p></p><p>The gentleman who sent me this email (Jim Mullowney) is someone who I met at the Northeast private well conference in November in CT. Jim just met with the Chairman of the EPA Science Advisory Board, Tom Zeller, last week to discuss this.<o:p></o:p></p><p> <o:p></o:p></p><p>Any insight would be appreciated!<o:p></o:p></p><p>Kira<o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p>(See attached file: Cytotoxic Drug Contamination_Pharma_Cycle White Paper Sept 22 2011.pdf)<o:p></o:p></p><p>----- Forwarded by Kira Jacobs/R1/USEPA/US on 01/04/2012 05:55 PM -----<o:p></o:p></p><p> <o:p></o:p></p><p>From: "Jim Mullowney" <<a href="mailto:jmullowney@pharma-cycle.com" target="_blank"><span style='color:windowtext;text-decoration:none'>jmullowney@pharma-cycle.com</span></a>><o:p></o:p></p><p>To: Kira Jacobs/R1/USEPA/US@EPA<o:p></o:p></p><p>Date: 11/28/2011 02:02 PM<o:p></o:p></p><p>Subject: It is illegal to go to the bathroom in RI if you are on a<o:p></o:p></p><p> Cytotoxic Chemotherapy drug<o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p> <o:p></o:p></p><p>Great meeting you the other day in Southbury CT. I was the guy with the ‘Pee in a cup’ program to save the world. I would love to meet with you and your staff to discuss the topic of cytotoxic Chemotherapy drugs excreted from patients, I know that sounds so inviting. Please read the attachment from the top environmental attorney in RI. This same legal opinion would apply with the EPA regs.<o:p></o:p></p><p> <o:p></o:p></p><p>Let me know when a good time to meet is.<o:p></o:p></p><p> <o:p></o:p></p><p>Jim(See attached file: Memorandum on Chemo drugs in urine.pdf)<o:p></o:p></p><p> <o:p></o:p></p></div></div><p class=MsoNormal style='margin-bottom:12.0pt'><br>---<br>Note: As a courtesy to other listserv subscribers, please post messages to the listserv in plain text format to avoid the garbling of messages received by digest recipients.<br>---<br>TO SUBSCRIBE, go to: <a href="http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste" target="_blank">http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste</a><br>TO UNSUBSCRIBE, DO NOT REPLY TO THE LISTSERV. Please send an e-mail to <a href="mailto:pharmwaste-unsubscribe@lists.dep.state.fl.us">pharmwaste-unsubscribe@lists.dep.state.fl.us</a> -- the subject line and body of the e-mail should be blank.<br>If you believe you may be subscribed with a different email address, please visit the subscriber listing at <a href="http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste" target="_blank">http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste</a><br>FOR PROBLEMS: Contact List Administrator <a href="mailto:Laurie.Tenace@dep.state.fl.us">Laurie.Tenace@dep.state.fl.us</a><br>SEND MAIL to the list server at: <a href="mailto:pharmwaste@lists.dep.state.fl.us">pharmwaste@lists.dep.state.fl.us</a><o:p></o:p></p></div><p class=MsoNormal><br><br clear=all><br>-- <br>Stevan Gressitt, M.D.<br>Faculty Associate, University of Maine Center on Aging<br>Academic Member, Athens Institute for Education and Research<br>Athens, Greece<br>Medical Director, Umbrella, MHC<br>Founding Director, International Institute for Pharmaceutical Safety<br>University of New England, College of Pharmacy<br>Department of Pharmaceutical Sciences<br>Associate Professor of Clinical Psychiatry<br>University of New England, College of Osteopathic Medicine<br>314 Clark Road<br>Unity, Maine, 04988<br><a href="mailto:gressitt@gmail.com" target="_blank">gressitt@gmail.com</a> <br>Cell: 207-441-0291<br><a href="http://www.benzos.une.edu" target="_blank">www.benzos.une.edu</a><br><a href="http://www.safemeddisposal.com" target="_blank">www.safemeddisposal.com</a><o:p></o:p></p></div></body></html>